90 related articles for article (PubMed ID: 18470916)
61. Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma.
Zhu QY; Zhao GX; Li Y; Talakatta G; Mai HQ; Le QT; Young LS; Zeng MS
MedComm (2020); 2021 Jun; 2(2):175-206. PubMed ID: 34766141
[TBL] [Abstract][Full Text] [Related]
62. Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population.
Campos AHJFM; Moreira A; Ribeiro KB; Paes RP; Zerbini MC; Aldred V; de Souza CA; Neto CS; Soares FA; Vassallo J
Sci Rep; 2018 Jan; 8(1):1849. PubMed ID: 29382865
[TBL] [Abstract][Full Text] [Related]
63. Carcinogenesis of nasopharyngeal carcinoma: an alternate hypothetical mechanism.
Poh SS; Chua ML; Wee JT
Chin J Cancer; 2016 Jan; 35():9. PubMed ID: 26738743
[TBL] [Abstract][Full Text] [Related]
64. Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice?
Glaser SL; Clarke CA; Keegan TH; Chang ET; Weisenburger DD
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1474-88. PubMed ID: 26215294
[TBL] [Abstract][Full Text] [Related]
65. Hodgkin lymphoma incidence in ethnic enclaves in California.
Glaser SL; Chang ET; Clarke CA; Keegan TH; Yang J; Gomez SL
Leuk Lymphoma; 2015; 56(12):3270-80. PubMed ID: 25899402
[TBL] [Abstract][Full Text] [Related]
66. Different time trends by gender for the incidence of Hodgkin's lymphoma among young adults in the USA: a birth cohort phenomenon.
Zhu C; Bassig BA; Shi K; Boyle P; Guo H; Zheng T
Cancer Causes Control; 2014 Aug; 25(8):923-31. PubMed ID: 24879043
[TBL] [Abstract][Full Text] [Related]
67. Hodgkin lymphoma incidence in California Hispanics: influence of nativity and tumor Epstein-Barr virus.
Glaser SL; Clarke CA; Chang ET; Yang J; Gomez SL; Keegan TH
Cancer Causes Control; 2014 Jun; 25(6):709-25. PubMed ID: 24722952
[TBL] [Abstract][Full Text] [Related]
68. EBV in Hodgkin Lymphoma.
Massini G; Siemer D; Hohaus S
Mediterr J Hematol Infect Dis; 2009 Nov; 1(2):e2009013. PubMed ID: 21416003
[TBL] [Abstract][Full Text] [Related]
69. Clinical, molecular, and environmental risk factors for hodgkin lymphoma.
Maggioncalda A; Malik N; Shenoy P; Smith M; Sinha R; Flowers CR
Adv Hematol; 2011; 2011():736261. PubMed ID: 21127715
[TBL] [Abstract][Full Text] [Related]
70. Non-Hodgkin's lymphoma in an Asian population: 1968-1992 time trends and ethnic differences in Singapore.
Seow A; Lee J; Sng I; Fong CM; Lee HP
Cancer; 1996 May; 77(9):1899-904. PubMed ID: 8646691
[TBL] [Abstract][Full Text] [Related]
71. Changing patterns of Hodgkin lymphoma incidence in Singapore.
Hjalgrim H; Seow A; Rostgaard K; Friborg J
Int J Cancer; 2008 Aug; 123(3):716-9. PubMed ID: 18470916
[TBL] [Abstract][Full Text] [Related]
72. On the aetiology of Hodgkin lymphoma.
Hjalgrim H
Dan Med J; 2012 Jul; 59(7):B4485. PubMed ID: 22759852
[TBL] [Abstract][Full Text] [Related]
73. A sharp rise in the incidence of Hodgkin's lymphoma in young adults in Israel.
Ariad S; Lipshitz I; Benharroch D; Gopas J; Barchana M
Isr Med Assoc J; 2009 Aug; 11(8):453-5. PubMed ID: 19891230
[TBL] [Abstract][Full Text] [Related]
74. Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of Korea.
Koh YW; Kang HJ; Yoon DH; Suh C; Kim JE; Kim CW; Huh J
Ann Hematol; 2013 Dec; 92(12):1653-60. PubMed ID: 23832190
[TBL] [Abstract][Full Text] [Related]
75. Frailty modeling of the bimodal age-incidence of Hodgkin lymphoma in the Nordic countries.
Grotmol T; Bray F; Holte H; Haugen M; Kunz L; Tretli S; Aalen OO; Moger TA
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1350-7. PubMed ID: 21558495
[TBL] [Abstract][Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
